{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:42:24Z","timestamp":1791225744541,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":1847,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Milgrom Family Support Fund for Research in Military Medicine"},{"DOI":"10.13039\/501100000833","name":"Rosetrees trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Microbiology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.resmic.2018.04.008","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T12:12:06Z","timestamp":1526472726000},"page":"531-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Combined bacteriophages and antibiotics as an efficient therapy against VRE Enterococcus faecalis in a mouse model"],"prefix":"10.1016","volume":"169","author":[{"given":"Daniel","family":"Gelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaul","family":"Beyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda","family":"Lerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Poradosu-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunit","family":"Coppenhagen-Glazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9967-730X","authenticated-orcid":false,"given":"Ronen","family":"Hazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmic.2018.04.008_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.idc.2016.02.006","article-title":"Vancomycin-resistant Enterococci: therapeutic challenges in the 21st century","volume":"30","author":"Miller","year":"2016","journal-title":"Infect Dis Clin N Am"},{"key":"10.1016\/j.resmic.2018.04.008_bib2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/jac\/dkm237","article-title":"Evaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model","volume":"60","author":"Arias","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.resmic.2018.04.008_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/TA.0000000000001809","article-title":"The history and promising future of phage therapy in the military service","author":"Gelman","year":"2018","journal-title":"J\u00a0Trauma Acute Care Surg"},{"key":"10.1016\/j.resmic.2018.04.008_bib4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","article-title":"Bacteriophage therapy","volume":"45","author":"Sulakvelidze","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resmic.2018.04.008_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/bact.1.2.14590","article-title":"Pros and cons of phage therapy","volume":"1","author":"Loc-Carrillo","year":"2011","journal-title":"Bacteriophage"},{"key":"10.1016\/j.resmic.2018.04.008_bib6","series-title":"Bacteriophages: biology and applications","author":"Kutter","year":"2004"},{"key":"10.1016\/j.resmic.2018.04.008_bib7","series-title":"Antibiotic resistance threats in the United States, 2013","author":"Centres for Disease Control and Prevention (US)","year":"2013"},{"key":"10.1016\/j.resmic.2018.04.008_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.resmic.2018.04.008_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12894-017-0283-6","article-title":"Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial","volume":"17","author":"Leitner","year":"2017","journal-title":"BMC Urol"},{"key":"10.1016\/j.resmic.2018.04.008_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrd4695","article-title":"Bacteriophage therapies re-enter clinical trials","volume":"14","author":"Kingwell","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.resmic.2018.04.008_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/138920110790725401","article-title":"Phage therapy in clinical practice: treatment of human infections","volume":"11","author":"Kutter","year":"2010","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.resmic.2018.04.008_bib12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/cid\/cix188","article-title":"Phage therapy: considerations and challenges for development","volume":"64","author":"Reindel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resmic.2018.04.008_bib13","article-title":"Refractory Pseudomonas bacteremia in a 2-year-old sterilized by bacteriophage therapy","author":"Duplessis","year":"2017","journal-title":"J\u00a0Pediatr Infect Dis Soc"},{"key":"10.1016\/j.resmic.2018.04.008_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resmic.2018.04.008_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13054-017-1709-y","article-title":"Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report","volume":"21","author":"Jennes","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.resmic.2018.04.008_bib16","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1128\/AAC.44.12.3434-3437.2000","article-title":"Efficacy of telithromycin (HMR 3647) against enterococci in a mouse peritonitis model","volume":"44","author":"Singh","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resmic.2018.04.008_bib17","doi-asserted-by":"crossref","first-page":"e0135571","DOI":"10.1371\/journal.pone.0135571","article-title":"Assessments of thioridazine as a helper compound to dicloxacillin against methicillin-resistant Staphylococcus aureus: in\u00a0vivo trials in a mouse peritonitis model","volume":"10","author":"Stenger","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.resmic.2018.04.008_bib18","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/AEM.00096-15","article-title":"Targeting Enterococcus faecalis biofilms with phage therapy","volume":"81","author":"Khalifa","year":"2015","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.resmic.2018.04.008_bib19","doi-asserted-by":"crossref","first-page":"e01308","DOI":"10.1128\/genomeA.01308-15","article-title":"Complete genome sequence of Enterococcus bacteriophage EFLK1","volume":"3","author":"Khalifa","year":"2015","journal-title":"Genome Announc"},{"key":"10.1016\/j.resmic.2018.04.008_bib20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fmicb.2018.00326","article-title":"Defeating antibiotic- and phage-resistant Enterococcus faecalis using a phage cocktail in\u00a0vitro and in a clot model","volume":"9","author":"Khalifa","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.resmic.2018.04.008_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.01164-17","article-title":"Complete genome sequences of three Bacillus anthracis bacteriophages","volume":"6","author":"Alkalay","year":"2018","journal-title":"Genome Announc"},{"key":"10.1016\/j.resmic.2018.04.008_bib22","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1038\/srep09743","article-title":"MICCA: a complete and accurate software for taxonomic profiling of metagenomic data","volume":"5","author":"Albanese","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.resmic.2018.04.008_bib23","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1128\/AAC.47.8.2706-2709.2003","article-title":"In\u00a0vivo efficacy of the ketolide ABT-773 (cethromycin) against enterococci in a mouse peritonitis model","volume":"47","author":"Pai","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resmic.2018.04.008_bib24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0305-4179(99)00017-0","article-title":"Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model","volume":"25","author":"Felts","year":"1999","journal-title":"Burns"},{"key":"10.1016\/j.resmic.2018.04.008_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/510015a","article-title":"Phage therapy gets revitalized","volume":"510","author":"Reardon","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.resmic.2018.04.008_bib26","first-page":"703","article-title":"Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence","volume":"215","author":"Oechslin","year":"2016","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.resmic.2018.04.008_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.resmic.2012.08.008","article-title":"Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa","volume":"164","author":"Knezevic","year":"2013","journal-title":"Res Microbiol"},{"key":"10.1016\/j.resmic.2018.04.008_bib28","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/AEM.02850-14","article-title":"Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity","volume":"81","author":"Kamal","year":"2015","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.resmic.2018.04.008_bib29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3389\/fmicb.2017.00837","article-title":"The bacteriophage EF-P29 efficiently protects against lethal vancomycin-resistant Enterococcus faecalis and alleviates gut microbiota imbalance in a murine bacteremia model","volume":"8","author":"Cheng","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.resmic.2018.04.008_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tim.2015.12.011","article-title":"Evolutionary rationale for phages as complements of antibiotics","volume":"24","author":"Torres-Barcelo","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.resmic.2018.04.008_bib31","first-page":"267","article-title":"Phage therapy: past history and future prospects","volume":"47","author":"Carlton","year":"1999","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.resmic.2018.04.008_bib32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3389\/fmicb.2017.00981","article-title":"Phage therapy: past, present and future","volume":"8","author":"Abedon","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.resmic.2018.04.008_bib33","doi-asserted-by":"crossref","first-page":"e24872","DOI":"10.4161\/bact.24872","article-title":"What are the limitations on the wider therapeutic use of phage?","volume":"3","author":"Henein","year":"2013","journal-title":"Bacteriophage"},{"key":"10.1016\/j.resmic.2018.04.008_bib34","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3389\/fmicb.2015.01543","article-title":"Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances","volume":"6","author":"Francino","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.resmic.2018.04.008_bib35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1128\/IAI.70.1.204-210.2002","article-title":"Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium","volume":"70","author":"Biswas","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.resmic.2018.04.008_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","article-title":"Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen","volume":"22","author":"Roach","year":"2017","journal-title":"Cell Host Microbe"}],"container-title":["Research in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923250818300640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923250818300640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:14:48Z","timestamp":1760332488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923250818300640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0923250818300640"],"URL":"https:\/\/doi.org\/10.1016\/j.resmic.2018.04.008","relation":{},"ISSN":["0923-2508"],"issn-type":[{"value":"0923-2508","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined bacteriophages and antibiotics as an efficient therapy against VRE Enterococcus faecalis in a mouse model","name":"articletitle","label":"Article Title"},{"value":"Research in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmic.2018.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}